The application deadline to apply for financial support through the United States Department of Health and Human Services (HHS) Provider Relief Fund Payment Portal has been extended from July 24 to August 3, 2020. The more than $4 billion…

A team of Swedish and Swiss researchers recently published a systematic review of the literature on reducing the risks of microbial transmission in dental aerosols in the Journal of Dental Research. Takeaways from the review include the…

A new bill, HR 7286 Quit Because of COVID-19 Act, has been introduced to the United States House of Representatives. Supported by the American Dental Association and other stakeholders, the legislation would require the federal government…

Concerned about your risk of COVID-19 while treating patients in your dental practice, having your kids attend in-person school, or shopping at your local grocery store? Well, Georgia Tech’s new Event Risk Assessment Planning Tool provides…

Terri Patrick, RDH, MS, CHES—an orofacial myofunctional therapist—is blogging for Dimensions of Dental Hygiene about COVID-19. In previous blogs the challenges of breathing while wearing N95 masks and the benefits of nasal…

Skin rashes are well known symptoms of COVID-19, especially among young people. Now Spanish researchers have found that a rash within the oral cavity may also be indicative of infection with the novel coronavirus. In a small study of 21…

In response to a surge in new COVID-19 cases, California Governor Gavin Newsom has implemented a second shutdown of the state. On July 13, Newsom ordered the closure of bars, indoor restaurants, movie theaters, and wineries in all 58…

With the continued growth of the novel coronavirus across much of the Southern and Western United States, ensuring that health care providers—including oral health professionals—have the necessary personal protective equipment (PPE) remains…

The United States Department of Health and Human Services (HHS) has made more than $4 billion of provider relief funds available to hospitals serving vulnerable patients of low socioeconomic status, those located in rural and small…

Results of a survey study with more than 50,000 participants showed that the regular use of proton pump inhibitors (PPIs)—medications used to reduce stomach acid—raised the risk of testing positive for COVID-19. The risk was higher among…